By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Med BioGene today said that its shareholders have approved its commercialization partnership with Precision Therapeutics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.